Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.


TSXV:NGEN - Post by User

Post by stargazer1on Dec 27, 2023 10:40am
207 Views
Post# 35801106

Volume going gangbusters, as well as the price

Volume going gangbusters, as well as the priceMarket has been open for less than an hour and already 82,000 shares traded, 10,000 in just the last 5 minutes. Price already up 6% from yesterday's closing which was a new high for the year. Already well surpassed that price. At $1.85. Still no new news, BUT some people must know something. The volume in the last two days is ridiculous. BUT NOT RIDICULOUS IF YOU KNOW SOMETHING. I don't, we don't, but I would say that the odds are in our favor. How many other people out there are watching our stock. Considering our normal volume, I would say close to zilch. I say that we are at an advantage in seeing what is happening. In response to that I just sold a bunch of my other stocks and bought more shares at $1.85. I figure that it's worth the risk. More than worth the risk. If a major press release is released soon, even today, which says something, like the preliminary people that have started the are already getting results, the stock will blast upward, not giving other people time to get in at these prices. Of course, any press release could be a dud, which would mean that the stock would back off. But what the hey. That's the way. Long term this is a winner big time, or not. But I still like the odds. Just saying. You might want to take a chance here and at least buy a few shares. Good luck, and Happy New Year. Buy now and you may really have a Happy New Year.
<< Previous
Bullboard Posts
Next >>